Kiniksa Pharmaceuticals International, plc (KNSA) Total assets 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) total assets at each fiscal year-end, per SEC filings.
$763.6MFY2025 · since FY2021: $232.8M → $763.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $763.6M | +31.5% |
| FY2024 | $580.6M | +10.3% |
| FY2023 | $526.3M | +14.5% |
| FY2022 | $459.7M | +97.5% |
| FY2021 | $232.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KNSA financial trends
KNSA RevenueKNSA Net incomeKNSA Net marginKNSA Gross profitKNSA Gross marginKNSA Operating incomeKNSA Operating marginKNSA Operating cash flowKNSA Free cash flowKNSA Capital expendituresKNSA Return on equityKNSA Stock buybacksKNSA Dividends paidKNSA Total liabilitiesKNSA Shareholders’ equityKNSA overview →